Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Vitamin D to Prevent Acute Respiratory Tract Infections
BMJ; ePub 2017 Feb 15; Martineau, et al
Vitamin D supplementation in patients who are vitamin D deficient is safe and protects against acute respiratory tract infection overall, a recent study found. This meta-analysis of individual participant data included 10,933 participants from 25 randomized trials. Placebo-controlled trials of supplementation with vitamin D or vitamin D2 of any duration were eligible for inclusion. Researchers found:
- Vitamin D supplementation reduced the risk of acute respiratory tract infection among all participants (adjusted OR, 0.88).
- Benefit was greater in participants receiving daily or weekly vitamin D without additional bolus doses and was strongest in those with profound vitamin D deficiency at baseline.
- Vitamin D did not influence the proportion of participants experiencing at least 1 serious adverse event (aOR, 0.98).
Citation:
Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. [Published online ahead of print February 15, 2017]. BMJ. doi:10.1136/bmj.i6583.
This meta-analysis is fairly amazing and lends strong support to the idea that vitamin D metabolism affects more than bones alone. For years, we have known that vitamin D is closely linked to calcium absorption and metabolism, and that vitamin D deficiency can lead to osteoporosis and muscle weakness. More recently, epidemiologic studies have shown a relationship between low levels of vitamin D and illnesses such as colon, breast and prostate cancer, hypertension, multiple sclerosis, diabetes, dementia, pain syndromes, arthritis, and congestive heart failure. 1 The challenge with interpreting data from these observational studies is determining whether a causal relationship exists between the low vitamin D levels and the outcome in question, and randomized trials have not supported a causal relation in many of these instances. The current study strongly supports correcting vitamin D deficiency to protect against URIs. Interestingly, a recent Cochrane review concluded that there is high quality evidence that vitamin D decreases asthma exacerbations by 40-60% in individuals with mild to moderate asthma.2 The effect on asthma may be mediated by a decrease in URI with vitamin D supplementation. Given the small or non-existent risk with vitamin D supplementation, and the high benefit in individuals who are vitamin D deficient, we may consider using this knowledge tomorrow in our patients who have or are at risk for vitamin D deficiency and/or have respiratory illness that increases their risk if they get an upper respiratory infection. —Neil Skolnik, MD